Repeated Examinations for Typing Pulmonary Embolism

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSahlgrenska University Hospital

About this trial

PURPOSE

The two related purposes of the RE-TyPE study are:

1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital

HYPOTHESES

1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital

Eligibility criteria

Qualifiers

Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital

Written informed consent

Disqualifiers

Low risk, intermediate-low risk or high risk PE*

>48 hours since arrival to hospital

Expected inability to comply with the protocol (e.g. dementia)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Sahlgrenska University Hospital

Lead sponsor

Gothia Forum - Center for Clinical Trial

Collaborator